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Abstract

Author Manuscript

A subtype of microglia is defined by the morphological appearance of the cells as rod-shaped.
Little is known about this intriguing cell type, as there are only a few case reports describing rodshaped microglia in the neuropathological literature. Rod-shaped microglia were shown recently to
account for a substantial proportion of the microglia cells in the hippocampus of both demented
and cognitively intact aged individuals. We hypothesized that aging could be a defining feature in
the occurrence of rod-shaped microglia. To test this hypothesis, two independent series of autopsy
cases (total n=168 cases), which covered the adult lifespan from 20 – 100+ years old, were
included in the study. The presence or absence of rod-shaped microglia was scored on IBA1
immunohistochemically stained slides for the hippocampus and cortex. We found that age was one
of the strongest determinants for the presence of rod-shaped microglia in the hippocampus and the
cortex. We found no association with the presence of rod-shaped microglia and a self-reported
history of a TBI. Alzheimer’s disease related pathology was found to influence the presence of
rod-shaped microglia, but only in the parietal cortex and not in the hippocampus or temporal
cortex. Future studies are warranted to determine the functional relevance of rod-shaped microglia
in supporting the health of neurons in the aged brain, and the signaling processes that regulate the
formation of rod-shaped microglia.
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1. Introduction
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Microglia are the resident tissue macrophage of the central nervous system (CNS). In the
healthy CNS, microglia form a network of nearly uniformly distributed cells throughout the
tissue, with thin highly ramified cell processes. Changes in microglia morphology away
from the ramified or ‘surveying’ type of cell are well described in the literature, but largely
center around the hypertrophic or ‘activated’ morphology. Despite recent studies defining a
number of additional microglia morphologies (Bachstetter et al., 2015, Roth et al., 2014,
Streit, 2006, Ziebell et al., 2012), little is known about the relevance of these morphological
changes to human brain health and disease.
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First described by Franz Nissl over 100 years ago (reviewed in (Graeber, 2010)), rod-shaped
microglia are a particularly intriguing morphologically-defined subtype. The modern
literature describing rod-shaped microglia is sparse, and is dominated by case reports, with
the exception of a recent study that determined the relative amount of rod-shaped microglia
in the hippocampus of different age-related neurodegenerative diseases (Bachstetter et al.,
2015). Rod-shaped microglia were found in approximately 60% of the cases, including a
subset of non-demented control cases, as well as in cases with different neurodegenerative
disease (Bachstetter et al., 2015). The high prevalence of rod-shaped microglia in individuals
65 years or older suggested that aging or an age-related degenerative process might be an
important predictor for the presence of rod-shaped microglia.
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In this study we sought to determine if aging, Alzheimer’s disease, or traumatic brain injury
(TBI) could be a defining feature in the occurrence of rod-shaped microglia in the human
brain. To this end we used two independent series of cases. The first series included 61 cases
that covered the adult lifespan from 20 – 96 years of age, which were free of advanced
neurodegenerative pathology. The second set of 107 cases were from an aged populationbased series, with an age range of 77 – 100+ years old, which included non-demented
controls and cases with Alzheimer’s disease. We found that older chronological age was a
strong predictor for the presence of rod-shaped microglia, even when controlling for
Alzheimer’s disease pathology. Our data suggest that there may be an age-related change to
neurons or microglia, which we have yet to define, that predisposes the aged brain to the
presence of rod shaped microglia.

2. Materials and Methods
2.1 UK series: University of Kentucky human subjects, and tissue processing
A set of 61 autopsy cases were collected from the University of Kentucky (UK) bio tissue
repository (Table 1). The cases were selected to cover the adult lifespan from 20 - 96 years
of age. Cases were selected by the investigators (JHN and PTN) to be free of advanced
neurodegenerative pathology. Exclusion criteria included pathologically confirmed
Neurobiol Aging. Author manuscript; available in PMC 2018 April 01.
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neurodegenerative disease: specifically, but not limited to, advance disease pathology
associated with Alzheimer’s disease, dementia with Lewy bodies, hippocampal sclerosis of
aging, and vascular dementia. To identify rod-shaped microglia, brains were stained with the
IBA1 (ionized calcium binding adaptor molecule 1) antibody, which is used as a pan marker
of macrophages / microglia in the brain. Paraffin-embedded tissue was processed, 8μm-thick
sections were cut, and immunohistochemical (IHC) staining was done using the primary
antibody: IBA1 (rabbit polyclonal, 1:1,000 IHC, Wako Pure Chemical Industries, Richmond,
VA). A biotinylated secondary antibody (Vector Laboratories) was amplified using avidinbiotin substrate (ABC solution, Vector Laboratories catalog no. PK-6100), followed by color
development in Nova Red (Vector Laboratories). The Aperio ScanScope XT digital
slidescanner was used to image the entire stained slide at 40x magnification to create a
single high-resolution digital image. A tissue section from the hippocampus and the frontal
cortex was analyzed by two observers blind to the experimental conditions (YH and DA).
The observers exhaustively inspected the gray matter of the entire slides for the presence of
rod-shaped microglia at a minimum of 8x magnification. Presence of rod-shaped microglia
was defined as at least 1 clearly defined rod-shaped microglia: Figure 1 shows examples of
cells defined as rod-shaped microglia.
2.2 AI-ACT series: Aging, Dementia and Traumatic Brain Injury study of the Allen Institute
(AI) for Brain Science

Author Manuscript

The Aging, Dementia and Traumatic Brain Injury Study is a series of 107 autopsy cases with
and without a history of traumatic brain injury drawn from the Adult Changes in Thought
(ACT) study (AI-ACT)) (Table 1). Data used for the current project are publically available
through the AI website (© 2016 Allen Institute for Brain Science. Aging, Dementia and
TBI. Available from: http://aging.brain-map.org/overview/explore). High magnification
digital histopathological images of the entire physical slides are available to download for
three brain regions—hippocampus, temporal cortex, and parietal cortex—for a number of
neuropathological stains. Additional information is available in the AI-ACT database,
including results from extensive biochemical assays, and clinical information about the
cases. To determine how often rod-shaped microglia were found in this sample population,
the digital histopathological images of IBA1 for the hippocampus, temporal cortex and
parietal cortex were downloaded (all regions were not available for all cases), and were
independently scored by three observers blind to the experimental conditions (YH, DA, and
ADB) for the presence or absence of rod-shaped microglia in the gray matter. Presence of
rod-shaped microglia was defined as at least 1 clearly defined rod-shaped microglia: Figure
1 shows examples of cells defined as rod-shaped microglia.
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2.3 Statistics
JMP Pro Software version 12.0 or SAS 9.4 (SAS Institute, Inc.; Cary, NC, USA) was used
for statistical analysis. Statistical significance was set at 0.05. Contingency tables of
categorical variables (presence of rod shaped microglia, sex, age group, history of TBI) were
compared using the Pearson chi-square test or Fisher’s exact test. The Cochran-Armitage
Test was used to assess for a linear trend in the association between age and frequency of
rod-shaped microglia. Logistic regression was used to assess the variable of interest (age)
and potential confounders (sex, dementia status, Braak neurofibrillary tangle (NFT) stage,
Neurobiol Aging. Author manuscript; available in PMC 2018 April 01.
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and Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) neuritic plaque
rating) and to estimate odds ratios (OR) for the presence of rod-shaped microglia. Age
groups were generated by a median split into 20–69 years old and 70 years old or older for
the UK series, and 70–89 years old and 90 years old or older group for the AI-ACT series.
Availability of confounder variables differed in the UK and AI-ACT cohorts. For UK, only
sex (coded male = 1, female = 2) was available for all cases. For the AI-ACT series,
additional variables were available: sex was coded as male = 1, female = 2, Braak NFT stage
was coded as low (stage 0/I/II), moderate (III/IV), or high (V/VI); CERAD neuritic plaque
rating was coded as none, sparse, moderate, or frequent; dementia status was coded as no
dementia vs. dementia (DSM-IV criteria). Multivariable regression models to adjust
clinicopathological associations for potential confounding factors have been used multiple
times by our group (Abner et al., 2016, Abner et al., 2014, Ighodaro et al., 2017, Nelson et
al., 2010). Comparisons between the AI-ACT series versus UK series were done using a
logistic regression to determine ORs for presence of rod-shaped microglia in the
hippocampus of older aged individuals (70–89 years old).
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In preclinical animal models, TBI has been shown to be a strong initiator for the presence of
rod-shaped microglia; therefore, we sought to determine if a history of TBI exposure in the
AI-ACT series could be associated with the presence of rod-shaped microglia. As part of the
ACT study design participants were asked at initial enrollment to the study and at the
biannual re-evaluation about exposure to a brain injury that caused a loss of consciousness
(Dams-O’Connor et al., 2013). Cases reporting a history of TBI with a loss of consciousness
were compared to those without a history of TBI for the presence of rod-shaped microglia.
To determine if more severe TBI could be associated with the presence of rod-shaped
microglia, cases with a self-reported loss of consciousness of more than 10 minutes were
compared to the cases with no TBI exposure.

3. Results
3.1 Age is associated with increased presence of rod-shaped microglia in the University of
Kentucky (UK) aging series

Author Manuscript

The primary research question was to elucidate the clinical-pathological correlations
associated with the occurrence of rod-shaped microglia in postmortem hippocampal and
cortical tissue. We first sought to determine if aging was accompanied by an increase
incidence of IBA1+ rod-shaped microglia. Examples of rod-shaped microglia identified in
the tissue of the aging UK series are shown in Figure 1. In the hippocampus a significant
trend for an increased occurrence of any rod-shaped microglia with increasing age was
found (Fig 2A). Separating the cases into younger adults (20–69 years old; n=35) to the
older adults (70+ years old; n=26), at the time of death (using a median split of the cases),
we found a significantly greater proportion of any rod-shaped microglia in hippocampus of
older adults (46.2%) compared to younger adults (11.4%) (Fig 2B). The age-related increase
in the presence of rod-shape microglia remained significant when corrected for sex
(p=0.005). The OR for presence of rod-shaped microglia in the older adults versus the
younger adults was 6.64 (95% confidence interval (CI) 1.94–27.25), and when corrected for
sex the OR was 5.87 (95% CI 1.66–24.8); the reduction in magnitude was likely due to the
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fact that females in the UK series were both more likely to be older and more likely to have
rod-shaped microglia in the hippocampus. In the frontal cortex, a similar age-related
increase in the proportion of individuals with any rod-shaped microglia was found (Fig 2C–
D); however, this increase was not statistically significant.
To further explore the age-related differences in the occurrence of rod-shaped microglia, the
cases were subdivided by which brain region(s) rod-shaped microglia were found, as
follows: 1) in the hippocampus only, 2) in the cortex only, or 3) in both the cortex and the
hippocampus (Fig 3). In those individuals less than 70 years old, rod-shaped microglia were
found in the frontal cortex, or the hippocampus, but not in both the hippocampus and frontal
cortex (Fig 3). This was in contrast to the older adults, where 19.2% of the cases were found
to have rod-shaped microglia in the frontal cortex and hippocampus.
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3.2 Age, and not traumatic brain injury (TBI) or Alzheimer’s disease related pathology, was
associated with the presence of rod-shaped microglia in the AI-ACT series

Author Manuscript

To further explore the occurrence of rod-shaped microglia in older individuals we used the
public data repository released by the Allen Institute (AI) for Brain Science (© 2016 Allen
Institute for Brain Science. Aging, Dementia and TBI. Available from: http://aging.brainmap.org/overview/explore). Overall we found that the percentage of cases positive for rodshaped microglia in the hippocampus in the older aged individuals (70–89 years old) was
higher in the AI-ACT series compared to the UK series (UK = 42.9% 9/21; AI-ACT =
65.1% 28/430. The OR for AI-ACT (70–89 years old) vs UK series (70–89 years old) to
have rod-shaped microglia in the hippocampus was 2.49 (95% CI, 0.86–7.44). The data
suggested that increased age and/or Alzheimer’s disease pathology found in the AI-ACT
series in comparison to the UK series (Table 1) may be associated with the increased
presence of rod-shaped microglia in the AI-ACT series.
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Since the AI-ACT series contained oldest-old individuals, we also sought to determine
whether oldest-old age (90+ years old) was associated with increased presence of rodshaped microglia relative to younger old (70–89 years old). In the hippocampus, the
unadjusted OR for 90+ vs. 70–89 was 1.30 (95% CI 0.54–1.86), suggesting no significant
effect of oldest-old age on the presence of rod-shaped microglia in this region. In the parietal
cortex, the OR was 0.86 (95% CI 0.34–2.16), and in the temporal cortex the OR was 3.27
(95% CI 1.43–7.73), which may suggest that age effects are region-specific (Table 2). To
evaluate if age was independently associated with presence of rod-shaped microglia after
controlling for Alzheimer’s disease pathology in the AI-ACT series, a logistic regression
analysis was done to determine if sex, Braak NFT Stage, CERAD neuritic plaque score, and
dementia status were potential confounders of the age-microglia relationship. The age effect
remained significant in the temporal cortex (Fig 4A, Table 2) after adjustment, but there
were also strong effects for dementia and sparse and moderate plaques in the parietal cortex,
although confidence intervals were wide (Table 2). There were no significant associations
between rod-shaped microglia and AD pathology in the hippocampus or temporal cortex. In
all three regions, men were less likely than women to have rod-shaped microglia, but this
effect was only significant in the parietal cortex (Fig 4B, Table 2).
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Finally, comparing a self-reported history of TBI with a loss of consciousness to the
presence of rod-shaped microglia yielded no significant association (Fig 5A). No association
was found between the severity of TBI, as determined by an extended period of loss of
consciousness and the presence of rod-shaped microglia (Fig 5B). As some of the cases with
a history of TBI had the exposure more than 6 decades before their death, we sought to
compare only those cases with a TBI more proximal to the time of death. However, no
significant association was found between the presence of rod-shaped microglia, and the
individuals who had a first TBI exposure after the age of 60 years old (Fig 5C).

4. Discussion

Author Manuscript
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The present study investigated the clinical-pathological correlations associated with the
occurrence of rod-shaped microglia in postmortem hippocampal and cortical tissue. Using
two independent autopsy series, we found that age was one of the strongest determinants of
the presence of rod-shaped microglia in the hippocampus and the cortex. We found no
association with the presence of rod-shaped microglia and a self-reported history of a TBI.
Alzheimer’s disease related pathology was found to influence the presence of rod-shaped
microglia, but only in the parietal cortex and not in the hippocampus or temporal cortex.
This suggests that increased activation of microglia (number or hypertrophic morphology) as
seen in Alzheimer’s disease does not explain the increase number of rod-shaped microglia in
the brain. This is in agreement with our previous study, where we found a very weak
correlation between the total number of microglia in the CA1 region of the hippocampus and
the number of rod-shaped microglia (R2 = 0.008; p=0.28 Spearman r) (Bachstetter et al.,
2015). Thus, our results highlight that rod-shaped microglia may be more common than
once believed, particularly in individuals over age 70, and that the increased prevalence of
rod-shaped microglia cannot be explained by simply larger numbers of microglia or more
activated microglia.
4.1 Potential functions of rod-shaped microglia
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Experimentally, the most faithful way to induce rod-shaped microglia is by an interruption in
axonal transport either caused by a traumatic brain injury, optic nerve transection, or
axotomy (Ackman et al., 2006, Bachstetter et al., 2015, de Hoz et al., 2013, Sanders et al.,
2014, Streit et al., 1999, Yuan et al., 2015, Ziebell et al., 2012). Deficits in axonal transport
are thought to be an early molecular mechanism leading to neuronal loss in age-related
neurodegenerative diseases (Morfini et al., 2009). In the current study it is not possible to
determine if the rod-shaped microglia are associated specifically with neurons with deficits
in axonal transport. The occurrence of rod-shaped microglia in more than one brain region in
older individuals, as we found in this study, could indicate an age-related brain-wide change
inhibiting axonal transport. The lack of a strong association of rod-shaped microglia with
any one neurodegenerative disease, as we found in this study and in our previous work
(Bachstetter et al., 2015), could be explained by the shared degenerative mechanism of
axonal transport deficits seen in aging and age-related neurodegenerative diseases (Morfini
et al., 2009).
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The function of rod-shaped microglia is largely unknown. There has been some speculation
that rod-shaped microglia might provide a protective function to neurons, potentially by
surrounding less damaged neurons to promote survival of the neurons (Streit et al., 1999,
Trapp et al., 2007, Ziebell et al., 2012). Mechanistically, the neuroprotection could be
imparted through the process of synaptic stripping, to alter the excitability of the weakened
neuron (Trapp et al., 2007). Rod-shaped microglia may also provide trophic support through
some yet to be identified mechanism that would appear to be contact dependent (Streit et al.,
1999). An intriguing possibility would be that rod-shaped microglia are involved in a
process of mitochondria transfer, as was recently shown for astrocytes following stroke
(Hayakawa et al., 2016), however more work is needed to test this possibility.
4.2 Potential chemotaxis signals for the formation of rod-shaped microglia
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The presence of rod-shaped microglia associated with specific neurons, while adjacent
neurons are not associated with rod-shaped microglia, would suggest an active neuronmicroglia signal regulating the specificity of rod-shaped microglia to individual neurons.
Neurons are able to interact directly with microglia through a number of neuron-microglia
specific signaling pathways. A well-documented example of such a signaling pathway is the
neuron ligand, CX3CL1 and the microglia receptor, CX3CR1. The CX3CR1-CX3CL1
pathway is vital for the suppression of inflammatory responses from microglia. Importantly,
this pathway has been shown to be dysfunctional with age (Bachstetter et al., 2011, Corona
et al., 2010, Lyons et al., 2009). The age-related loss of CX3CL1 may reduce the contact
inhibition signals, thereby priming the aged brain for the formation of rod-shaped microglia.
Yet, rod-shaped microglia are not a defining feature in CX3CR1 KO mice (Cardona et al.,
2006, Rogers et al., 2011), so it is unlikely that this pathway is a sole driver for the
formation of rod-shaped microglia. Thus, there must also be a chemotaxis signal that is
released from the neuron to cause the recruitment of the microglia to the neuron. As
microglia, have been shown to constantly make brief contact with neurons (Tremblay et al.,
2010), the chemotaxis signal could be contact dependent and not a soluble factor released
from the neurons.
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The AI-ACT study includes an extensive array of histological and biochemical information,
including RNAseq. A superficial exploration of this data did not reveal any proteins or genes
at the tissue level that were associated with the presence or absence of rod-shaped microglia.
As rod-shaped microglia account for only a small percentage of the total microglia
population (Bachstetter et al., 2015), and the total microglia population only accounts for 5–
20% of the total glia population (van Rossum and Hanisch, 2004), it is likely at the tissue
level a rod-shaped microglia molecular signature may not be evident. Future studies using
laser capture microdissection would be needed to isolate individual neurons that are
associated with rod-shaped microglia and adjacent neurons and microglia which are not in
close association. Then a subtractive analysis could be done to determine the molecular
signature unique to the neuron associated with the rod-shaped microglia and that of the rodshaped microglia, compared to the adjacent neurons and microglia.
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A limitation of the study is that the AI-ACT series over-represents males and individuals
with a history of TBI, compared to the community-based sample of the larger Adult
Changes in Thought study. Methods for weighted analyses to extrapolate results to the larger
cohort are provided by AI (© 2016 Allen Institute for Brain Science. Aging, Dementia and
TBI. Available from: http://aging.brain-map.org/overview/explore), but were not used for
this study. Therefore, findings reported should be seen as specific to the AI-ACT series and
may not be representative of the larger cohort or the population in general. A second
limitation of our study is that more than half of the cases with a history of TBI, had the first
exposure to TBI many decades before death; thus, it is reasonable to assume that rod-shaped
microglia may have resolved over time. A third limitation of our study was that it was not
possible with the tissue available to provide a design-based stereological quantification of
the total number of microglia; thus, we cannot account for the effect of age-related increase
in microglia density that may influence the likelihood of detecting rod-shaped microglia in
the older aged individuals.
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A striking finding was the lack of rod-shaped microglia in the hippocampus of individuals
aged 40–69 years old. Leading causes of death are known to change across age groups.
Therefore, we hypothesized that differences in cause of death in the 40–69 years old group
could be associated with the lack of rod-shaped microglia in this group. In the younger
individuals (aged 20–69 years old), rod-shaped microglia were not found in the cases where
the cause of death was either cardiac associated, drug abuse, or sepsis. Rod-shaped microglia
were found in cases of pulmonary embolism, liver failure, or cancer. A limitation of this
study was that cause of death was known for only a subset of the individuals 60 years old or
older, so associations between cause of death and rod-shaped microglia could not be fully
determined. Future studies specifically investigating the relationship of cause of death and
rod-shaped microglia may be warranted.
4.4 Conclusion
In summation, our results highlight that aging, but not necessarily Alzheimer’s disease or a
history of TBI, is a defining feature in the presence of rod-shaped microglia in the human
brain. Future studies are warranted to determine the functional relevance of rod-shaped
microglia in supporting the health of neurons in the aged brain, and the signaling processes
that regulate the formation of rod-shaped microglia.
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•

Rod-shaped microglia are associated with aging in human hippocampus and
cortex.

•

Alzheimer’s disease influences the presence of rod-shaped microglia.

•

A history of traumatic brain injury was not associated with rod-shaped
microglia.
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Figure 1. Examples of rod-shaped microglia from the UK series
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(A) Numerous rod-shaped microglia are found throughout the CA1 region of the
hippocampus of an 86-year-old female. The arrow indicates the area shown at a higher
magnification in (B). (C) Long thin rod-shaped microglia, which appear to be surrounding a
pyramidal neuron, in the subiculum of a 39-year-old male, who had hypoxia / ischemia
pathology, and a pulmonary associated cause of death. (D) Example of rod-shaped microglia
seen in the frontal cortex of a 28-year-old female, who died of atherosclerotic disease. (E) A
number of long trains of rod-shaped microglia were found in the CA1 region of the
hippocampus of a 25-year-old female, who had hypoxia / ischemia pathology, and a
pulmonary associated cause of death. Scale bar = 50μm
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Figure 2. Association of aging on the presence of rod-shaped microglia
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(A) In the hippocampus a significant trend was found for an increasing occurrence of rodshaped microglia with increasing age (p=0.017, Cochran Armitage Trend Test). (B) A
significant increase in the occurrence of rod shaped microglia in the hippocampus was found
in those individuals 70-years or older (70+) at the time of death, compared to those
individuals 20–69-years old at the time of death (p=0.0033, Fisher Exact test) (C) A similar
pattern was found for the frontal cortex when plotted as age by decade (p=0.222, CochranArmitage Trend Test), or split into young adults (20–69-years old) and older adults (70+)
(p=0.089, Fisher Exact test). The number of cases in each group are shown in the bars.
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Figure 3. Regional heterogeneity in the occurrence of rod-shaped microglia in younger adults
versus aged adults
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Cases were subdivided by which brain region(s) rod-shaped microglia were found, as
follows: 1) in both the cortex and the hippocampus, 2) in the hippocampus only, 3) in the
cortex only. In younger adults (20–69 years old) rod shaped microglia were found in the
hippocampus, or in the frontal cortex, which is in contrast to the older adults (70+ years old)
(p=0.047, χ2 test). The number of cases in each group are shown in the bars.

Author Manuscript
Neurobiol Aging. Author manuscript; available in PMC 2018 April 01.

Bachstetter et al.

Page 15

Author Manuscript
Author Manuscript
Author Manuscript

Figure 4. Association of age and sex on the presence of rod-shaped microglia

The presence of rod-shaped microglia was determined in cases from the AI-ACT series. (A)
Age at the time of death was found to significantly contribute to an increase percentage of
cases positive for the presence of rod-shaped microglia. (B) Sex was also found to effect the
odds ratio that rod-shaped microglia would be found. See table 2 for summary or results.
The number of cases in each group are shown in the bars.
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Figure 5. Association between a history of traumatic brain injury (TBI) and the presence of rodshaped microglia in AI-ACT series

(A) A self-reported history of at least one TBI with a loss of consciousness of at least a few
seconds was not found associated with the presence of rod-shaped microglia. No association
with the presence of rod-shaped microglia was found with either: (B) a self-reported history
of at least one TBI with a loss of consciousness of more than 10 min; or a first TBI exposure
after the age of 60 years old. The number of cases in each group are shown in the bars.
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Case series characteristics

Author Manuscript

UK series

AI-ACT series

61

107

20–29

6 (9.8%)

0 (0%)

30–39

12 (19.7%)

0 (0%)

40–49

7 (11.5%)

0 (0%)

50–59

6 (9.8%)

0 (0%)

60–69

4 (6.6%)

0 (0%)

70–79

5 (8.2%)

12 (11.2%)

80–89

16 (26.2%)

45 (42.1%)

90–99

5 (8.2%)

43 (40.2%)

0 (0%)

7 (7.5%)

Male

27 (43.3%)

63 (58.9%)

Female

31 (50.8%)

44 (41.1%)

61 (100%)

57 (53.3%)

0 (0%)

50 (46.7%)

61 (100%)

28 (26.2%)

III/IV

0 (0%)

44 (41.1%)

V/VI

0 (0%)

32 (29.9%)

61 (100%)

24 (22.4%)

Sparse

0 (0%)

33 (30.8%)

Moderate

0 (0%)

25 (23.4%)

Frequent

0 (0%)

25 (23.4%)

Number of cases
Age

100+
Sex

Dementia status
No dementia
Dementia
Braak NFT stage
0/I/II

Author Manuscript

CERAD rating
None

Number of cases and percent of total cases for the series are shown in the table. Abbreviations: University of Kentucky bio tissue repository series
of cases (UK series). The Aging, Dementia and Traumatic Brain Injury Study series (© 2016 Allen Institute for Brain Science. Aging, Dementia
and TBI. Available from: http://aging.brain-map.org/overview/explore) (AI-ACT series). Braak neurofibrillary tangle (NFT) Stage. Consortium to
Establish a Registry for Alzheimer’s Disease (CERAD)
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1.15 (0.48–2.83)

0.42 (0.16–1.05)

1.30 (0.54–1.86)

unadjusted

2.81 (0.88–9.73)

V/VI vs. 0/I/II

0.80 (0.21–2.90
1.21 (0.31–4.71)

Moderate vs. None

Frequent vs. None

0.52 (0.09–2.84)

0.51 (0.12–2.07)

0.60 (0.15–2.28)

3.54 (0.72–19.52)

1.47 (0.47–4.67)

0.76 (0.25–2.23)

0.47 (0.17–1.21)

1.06 (0.40–2.80)

adjusted

1.00 (0.19–5.71)

3.21 (0.78–16.78)

2.50 (0.62–12.82)

0.68 (0.21–2.24)

0.56 (0.18–1.77)

1.97 (0.78–5.13)

0.26** (0.09–0.66)

0.86 (0.34–2.16)

unadjusted

1.30 (0.40–4.27)

1.65 (0.51–5.44)

1.10 (0.11–11.04)

1.38 (0.44–4.39)

5.81* (1.02–43.33)

1.42 (0.49–4.17)

1.21 (0.45–3.25)

1.76 (0.78–3.96)

0.63 (0.27–1.42)

3.27** (1.43–7.73)

unadjusted

6.00* (1.11–42.54)

0.41 (0.58–2.57)

0.37 (0.89–1.40)

4.03* (1.18–15.7)

0.20** (0.06–0.57)

1.04 (0.32–3.29)

adjusted

Parietal cortex

0.75 (0.15–3.58

1.57 (0.41–6.23)

2.11 (0.59–7.99)

0.91 (0.19–4.24

0.96 (0.31–2.88)

2.55 (0.96–7.20)

0.72 (0.29–1.75)

4.05** (1.63–10.79)

adjusted

p<0.005

p<0.05,

**

*

Odds ratio and 95% confidence intervals for logistic regression analysis are shown for the presence of rod-shaped microglia for each given independent variable (unadjusted), or with all the independent
variables included in the regression model (adjusted).

0.76 (0.21–2.67)

Sparse vs. None

CERAD neuritic plaque rating

1.47 (0.52–4.20)

III/IV vs. 0/I/II

Braak neurofibrillary tangle stage

Dementia vs. no dementia

Dementia status

Male vs. Female

Sex

90+ vs. 70–89

Age

Comparison

Hippocampus

Temporal cortex
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Odds ratios (95% CI) for presence of rod-shaped microglia in the AI-ACT series
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